HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul S Albert Selected Research

Peritoneal Diseases

12/2011Pre-Clinical Assessment of Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease.
2/2010Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72.
8/2008Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease.
3/2007Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease.
10/2005Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2.
12/2004Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul S Albert Research Topics

Disease

35Neoplasms (Cancer)
05/2024 - 02/2002
14Adenoma (Adenomas)
04/2012 - 06/2003
13Polyps
04/2012 - 06/2003
9Colorectal Neoplasms (Colorectal Cancer)
04/2012 - 06/2008
8Prostatic Neoplasms (Prostate Cancer)
04/2010 - 02/2004
7Inflammation (Inflammations)
01/2018 - 10/2007
6Peritoneal Diseases
12/2011 - 12/2004
5Lung Neoplasms (Lung Cancer)
02/2024 - 04/2019
5Gestational Diabetes (Gestational Diabetes Mellitus)
01/2020 - 11/2016
5Carcinogenesis
09/2012 - 01/2008
4Glioma (Gliomas)
04/2010 - 12/2007
4Carcinoma (Carcinomatosis)
02/2010 - 02/2002
4Adenomatous Polyps
06/2008 - 11/2004
3Fetal Weight
07/2023 - 01/2019
3Colonic Neoplasms (Colon Cancer)
01/2020 - 01/2009
3Hypoparathyroidism
12/2018 - 02/2012
3Obesity
06/2010 - 01/2009
3Squamous Cell Carcinoma of Head and Neck
07/2009 - 09/2005
3Breast Neoplasms (Breast Cancer)
01/2009 - 08/2002
2Infections
05/2024 - 04/2004
2Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2024 - 01/2019
2Central Nervous System Neoplasms
11/2023 - 12/2007
2Autoimmune Polyendocrinopathies (Schmidt Syndrome)
12/2018 - 09/2014
2Insulin Resistance
01/2018 - 01/2010
2Anovulation
10/2012 - 08/2011
2Hematologic Neoplasms (Hematological Malignancy)
09/2012 - 12/2007
2Endometriosis
01/2012 - 07/2010
2Thrombocytopenia (Thrombopenia)
02/2010 - 05/2009
2Proctitis
01/2008 - 07/2006
2Viremia
02/2007 - 04/2004
2Pancreatic Neoplasms (Pancreatic Cancer)
05/2006 - 12/2004
2Esophageal Neoplasms (Esophageal Cancer)
03/2004 - 12/2002
1Hepatitis
05/2024
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2023
1Sarcoma (Soft Tissue Sarcoma)
11/2023
1Long Term Adverse Effects
11/2023
1Neuroblastoma
11/2023
1Hodgkin Disease (Hodgkin's Disease)
11/2023
1Papillary Thyroid Cancer
10/2023
1COVID-19
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2021
1Malaria
01/2021

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
12/2020 - 06/2007
7Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2002
6CytokinesIBA
04/2016 - 09/2005
5Trastuzumab (Herceptin)FDA Link
12/2011 - 12/2004
4PesticidesIBA
05/2024 - 04/2019
4EnzymesIBA
12/2019 - 02/2009
4CalciumIBA
12/2018 - 02/2005
43-hydroxyflavoneIBA
03/2011 - 06/2008
3Glucose (Dextrose)FDA LinkGeneric
01/2020 - 11/2016
3Indicators and Reagents (Reagents)IBA
10/2012 - 06/2010
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2012 - 06/2003
3Interleukin-6 (Interleukin 6)IBA
03/2011 - 01/2009
3FlavonolsIBA
03/2011 - 06/2008
3InterleukinsIBA
03/2011 - 09/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2010 - 02/2004
3Anticonvulsants (Antiepileptic Drugs)IBA
02/2010 - 02/2009
3Amifostine (Ethyol)FDA LinkGeneric
01/2008 - 08/2005
3Prostate-Specific Antigen (Semenogelase)IBA
01/2008 - 02/2002
2beta Carotene (Betacarotene)FDA Link
01/2024 - 11/2004
2FluorocarbonsIBA
12/2023 - 10/2023
2Protons (Proton)IBA
11/2023 - 07/2008
2AntigensIBA
12/2020 - 12/2004
2Parathyroid Hormone (Parathormone)IBA
12/2018 - 09/2014
2Interleukin-8 (Interleukin 8)IBA
01/2018 - 09/2005
2Fatty Acids (Saturated Fatty Acids)IBA
01/2018 - 08/2005
2Estradiol (Delestrogen)FDA LinkGeneric
10/2012 - 08/2011
2Vitamin DFDA LinkGeneric
02/2012 - 02/2005
2Polychlorinated Biphenyls (PCBs)IBA
01/2012 - 07/2010
2Hormones (Hormone)IBA
08/2011 - 11/2003
2Interleukin-10 (Interleukin 10)IBA
03/2011 - 01/2009
2LeptinIBA
06/2010 - 11/2003
2Monoclonal AntibodiesIBA
02/2010 - 04/2009
2enzastaurinIBA
02/2010 - 05/2009
2Dietary FiberFDA Link
09/2009 - 06/2008
2Paclitaxel (Taxol)FDA LinkGeneric
07/2009 - 08/2008
2AzoxymethaneIBA
01/2009 - 01/2008
2SuspensionsIBA
01/2008 - 07/2006
2DNA (Deoxyribonucleic Acid)IBA
02/2007 - 02/2002
2Insulin-Like Growth Factor I (IGF-1)IBA
02/2005 - 12/2004
2Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
03/2004 - 12/2002
1Drinking WaterIBA
05/2024
1perfluorooctane sulfonic acidIBA
05/2024
1perfluorooctaneIBA
05/2024
1AcidsIBA
05/2024
1AtrazineIBA
02/2024
1SmokeIBA
01/2024
1alpha-TocopherolFDA Link
01/2024
1pentadecanoic acidIBA
07/2023
1InterferonsIBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022

Therapy/Procedure

12Radiotherapy
11/2023 - 02/2004
12Therapeutics
11/2023 - 08/2002
4Radioimmunotherapy
12/2011 - 12/2004
4Prostatectomy (Retropubic Prostatectomy)
04/2010 - 02/2002
2Injections
12/2018 - 02/2012
1Cell Transplantation
11/2023
1Proton Therapy
11/2023
1Ambulatory Care (Outpatient Care)
01/2021